102
Participants
Start Date
January 29, 2019
Primary Completion Date
March 15, 2019
Study Completion Date
March 17, 2019
Intravenous cannulation after intradermal injection of lidocaine via MicronJet600 microneedle device (1)
Intradermal administration of 100 µL of lidocaine (registrational number LS001516 by Federal Service for Surveillance in Healthcare of Russian Federation) via MicronJet600 microneedle device at the site of antecubital fossa of the left arm, followed by the insertion of 18G catheter in a cubital vein immediately after the lidocaine administration.
Intravenous cannulation after intradermal injection of saline via MicronJet600 microneedle device
Intradermal administration of 100 µL saline (registration number РN002134/01 by Federal Service for Surveillance in Healthcare of Russian Federation) via MicronJet600 microneedle device at the site of antecubital fossa of the right arm, followed by the insertion of 18G catheter in a cubital vein immediately after the saline administration.
Intravenous cannulation after intradermal injection of lidocaine via MicronJet600 microneedle device (2)
Intradermal administration of 100 µL of lidocaine (registrational number LS001516 by Federal Service for Surveillance in Healthcare of Russian Federation) via MicronJet600 microneedle device at the site of antecubital fossa of the left arm, followed by the insertion of 18G catheter in a cubital vein immediately after the lidocaine administration.
Intravenous cannulation after without prior interventions
insertion of 18G catheter in a cubital vein without prior interventions.
University Clinical Hospital №2 (I.M. Sechenov First Moscow State Medical University (Sechenov University)), Moscow
Collaborators (1)
NanoPass Technologies Ltd
INDUSTRY
I.M. Sechenov First Moscow State Medical University
OTHER